Related references
Note: Only part of the references are listed.Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
Nilesh Chande et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Splitting a Therapeutic Dose of Thioguanine May Avoid Liver Toxicity and Be an Efficacious Treatment for Severe Inflammatory Bowel Disease: A 2-Center Observational Cohort Study
Polychronis Pavlidis et al.
INFLAMMATORY BOWEL DISEASES (2014)
Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
Julian Panes et al.
GASTROENTEROLOGY (2013)
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Nilesh Chande et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
Natalie A. Molodecky et al.
GASTROENTEROLOGY (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis
Antje Timmer et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis
Miloslav Kverka et al.
BMC GASTROENTEROLOGY (2011)
Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis
Dirk P. van Asseldonk et al.
DIGESTIVE AND LIVER DISEASE (2011)
Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease-Proceedings of the first Thiopurine Task Force meeting
Dirk P. van Asseldonk et al.
DIGESTIVE AND LIVER DISEASE (2011)
Incidence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Azathioprine
Philippe Seksik et al.
INFLAMMATORY BOWEL DISEASES (2011)
GRADE guidelines: 3. Rating the quality of evidence
Howard Balshem et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
GRADE guidelines: 5. Rating the quality of evidence-publication bias
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Thiopurine Therapy in Inflammatory Bowel Disease Patients: Analyses of Two 8-Year Intercept Cohorts
B. Jharap et al.
INFLAMMATORY BOWEL DISEASES (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
6-Thioguanine therapy in Crohn's disease-Observational data in Swedish patients
S. H. C. Almer et al.
DIGESTIVE AND LIVER DISEASE (2009)
Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines
S. Ben-Horin et al.
GUT (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients
N. K. H. de Boer et al.
DIGESTIVE AND LIVER DISEASE (2008)
Further Experience with the Use of 6-Thioguanine in Patients with Crohn's Disease
Azhar Ansari et al.
INFLAMMATORY BOWEL DISEASES (2008)
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD
Nanne K. H. de Boer et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2007)
A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease
Alexander Teml et al.
WIENER KLINISCHE WOCHENSCHRIFT (2007)
Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease
Asghar Qasim et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
Toxicity of 6-thioguanine:: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine -: Some evidence for dose or metabolite level dependent effects?
L. P. L. Gilissen et al.
DIGESTIVE AND LIVER DISEASE (2007)
6-thioguanine treatment in inflammatory bowel disease: A critical appraisal by a European 6-TG working party
NKH de Boer et al.
DIGESTION (2006)
A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine
J Seiderer et al.
JOURNAL OF HEPATOLOGY (2005)
Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease
RB Gearry et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2004)
6-thioguanine can cause serious liver injury in inflammatory bowel disease patients
MC Dubinsky et al.
GASTROENTEROLOGY (2003)
An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy
MC Dubinsky et al.
INFLAMMATORY BOWEL DISEASES (2001)
Share Paper
